Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

High-Risk Resectable NSCLC × pembrolizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 123 Squamous Cell Carcinoma of Head and Neck 56 Melanoma 56 Parkinson Disease 4, Autosomal Dominant Lewy Body 51 Lung Neoplasms 48 Triple Negative Breast Neoplasms 41 Breast Neoplasms 39 Neoplasm Metastasis 37 Neoplasms 36 Colorectal Neoplasms 33 Carcinoma, Renal Cell 27 Stomach Neoplasms 22 Ovarian Neoplasms 22 Endometrial Neoplasms 22 Carcinoma, Transitional Cell 22 Uterine Cervical Neoplasms 19 Urinary Bladder Neoplasms 19 Pancreatic Neoplasms 18 Head and Neck Neoplasms 18 Esophageal Neoplasms 18 Carcinoma 16 Carcinoma, Hepatocellular 12 Recurrence 11 Glioblastoma 11 Carcinoma, Squamous Cell 11 Mouth Neoplasms 9 Prostatic Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Lymphoma 7 Laryngeal Neoplasms 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡